Immune dysfunction in patients with diabetes mellitus (DM)

FEMS Immunology and Medical Microbiology

Volumn 26, Issue 3-4, 1999, Pages 259-265

  Geerlings, Suzanne E ^a   Hoepelman, Andy I M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Diabetes mellitus; Immune dysfunction; Infection

Indexed keywords

CYTOKINE;

ARTICLE; CANDIDA ALBICANS; CELL FUNCTION; CHEMOTAXIS; COMPLEMENT FACTOR; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; DISEASE COURSE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOPATHOGENESIS; INFECTION; MACROPHAGE; MONOCYTE; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

ANTIBODY FORMATION; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; IMMUNITY, CELLULAR; INFECTION;

EID: 0033485391     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00142-X     Document Type: Article

References (45)

1. Deresinski, S. (1995) Infections in the diabetic patient: Strategies for the clinician. Infect. Dis. Rep. 1, 1-12.
2. Carton, J.A., Maradona, J.A., Nuno, F.J., Fernandez-Alvarez, R., Perez-Gonzalez, F. and Asensi, V. (1992) Diabetes mellitus and bacteraemia: A comparative study between diabetic and non-diabetic patients. Eur. J. Med. 1, 281-287.
3. Lederman, M.M., Schiffman, G.A. and Rodman, U.M. (1981) Pneumococcal immunization in adults. Diabetes 30, 119-121.
4. Beam, T.R.J., Crigler, E.D., Goldman, J.R. and Schifmann, G. (1980) Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics. J. Am. Med. Assoc. 244, 2641-2644.
5. Li Volti, S., Caruso-Nicoletti, M., Biazzo, F., Sciacca, A., Mandara, G., Mancuso, M. and Mollica, F. (1998) Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus. Arch. Dis. Child. 78, 54-57.
6. Moutschen, M.P., Scheen, A.J. and Lefebvre, P.J. (1992) Impaired immune responses in diabetes mellitus: Analysis of the factors and mechanisms involved in relevance to the increased susceptibility of diabetic patients to specific infections. Diabetes Metab. 18, 187-201.
7. Casey, J.I., Heeler, B.J. and Klyshevich, K.A. (1977) Impaired response of lymphocytes of diabetic subjects to antigen of Slaphylococciis aurciis. J. Infect. Dis. 136, 495-501.
8. Maccuish, A.C., Urbaniak, S.J., Campbell, C.J., Duncan, L.J.P. and Irvine, W. (1974) Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetics. Diabetes 23, 708-712.
9. Plouffe, J.F., Suva, J., Fekety, F.R.J. and Allen, J.L. (1978) Cell-mediated immunity in diabetes mellitus. Infect. Immun. 21, 425-429.
10. Vergani, D., Johnston, C., B-Abdullah, N. and Barnelt, A.H. (1983) Low serum C4 concentrations: an inherited predisposition to insulin dependent diabetes? Br. Med. J. 286, 926-928.
11. Mysliwska, J., Zorena, K., Bakowska, A., Skuratowicz-Kubica, A. and Mysliwski, A. (1998) Significance of tumor necrosis factor-a in patients with long-standing type-1 diabetes mellitus. Horm. Metab. Res. 30, 158-161.
12. Pickup, J.C. and Crook, M.A. (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41, 1241-1248.
13. Zozulinska, D., Majchrzak, A., Sobieska, M., Wiktorowicz, K. and Wierusz-Wysocka, B. (1999) Scrum interleukin-8 level is increased in diabetic patients. Diabetologia 42, 117-118.
14. Mooradian, A.D., Reed, R.L., Meredith, K.E. and Scuderi, P. (1991) Serum levels of tumor necrosis factor and ILlctand ILlβ in diabetic patients. Diabetes Care 14, 63-65.
15. Ohno, Y., Aoki, N. and Nishimura, A. (1993) In vitro production of interleukin-1, interIeukin-6, and tumor necrosis factor-a in insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 77, 1072-1077.
16. Ziegler-Heitbrock, H.W.L., Wedel, A., Schraut, W., Strobel, M., Wendelgass, P., Sternsdorf, T., Bauerle, P.A., Haas, J.G. and Riethmuller, G. (1994) Tolerance to lipopolysaccharide involves mobilization of nuclear factor kB with predominance of p50 homodimers. J. Biol. Chem. 269, 17001-17004.
17. Morohoshi, M., Fujisawa, K., Uchimura, I. and Numano, F. (1995) The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes. Ann. NY Acad. Sei. 748, 562-570.
18. Rcinhold, D., Ansorge, S. and Schleicher, E.D. (1996) Elevated glucose levels stimulate transforming growth factor-bl (TGF-B1),-suppress intcrleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. Horm. Metab. Res. 28, 267-270.
19. Stehouwer, C., Lambert, J., Donker, A. and van Hinsbergh, V.W.M. (1997) Endothelial dysfunction and pathogencsis of diabetic angiopathy. Cardiovasc. Res. 34, 55-68.
20. Vlassara, II., Brownlee, M., Manogue, K.R., Dinarello, C.A. and Pasagian, A. (1988) Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science 240, 1546-1548.
21. Imani, F., Horii, Y., Suthanthiran, M., Skolnik, E.Y., Makita, Z., Sharma, V., Sehajpal, P. and Vlassara, H. (I993) Advanced glycosylation endproduct-specific receptors on human and rat T-Iymphocytes mediate synthesis of interferon gamma: Role in tissue remodeling. J. Exp. Med. 178, 2165-2172.
22. Wahl, P.W., Savage, P.J., Psaty, B.M., Orchard, T.J., Robbins, J.A. and Tracy, R.P. (1998) Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet 352, 1012-1015.
23. Hosteller, M.K. (1990) Perspcclives in diabetes. Handicaps to host defense. Effects of hyperglycemia on C3 and Ctmtliilii alhicans. Diabetes 39, 271-275.
24. Geerlings, S.E., Brouwer, E.G., Gaastra, W., Verhoef, J. and Hoepelman, A.I.M. (1999) The effect of glucose and pH on uropathogenic and non-uropathogenic Esehcrichia coli: Studies using urine from diabetics and non-diabetics. J. Med. Microbiol. 48, 535-539.
25. Tater, D., Tepaut, B., Bercovici, J.P. and Youinou, P. (1987) Polymorphonuclear cell derangements in type I diabetes. Horm. Metab. Res. 19, 642-647.
26. Tan, J.S., Anderson, J.L., Watanakunakorn, C. and Phair, J.P. (1975) Neutrophil dysfunction in diabetes mellitus. J. Lab. Clin. Med. 85, 26-33.
27. Andersen, B., Goldsmith, G.H. and Spagnuolo, P.J. (1988) Neutrophil adhesive dysfunction in diabetes mellitus; the role of cellular and plasma factors. J. Lab. Clin. Med. Ill, 275-285.
28. Bloomgarden, Z.T. (1998) Endothelial dysfunction, neuropathy and the diabetic foot, diabetic mastopathy, and erectile dysfunction. Diabetes Care 21, 183-189.
29. Zargar, A.H., Shah, N.A., Masoodi, S.R., Laway, B.A., Dar, F.A., Khan, A.R., Sofi, F.A. and Wani, A.I. (1998) Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus. Postgrad. Med. J. 74, 665-668.
30. Wellinghausen, N., Schromm, A.B., Seydel, U., Brandenburg, K., Luhm, J., Kirchner, H. and Rink, L. (1996) Zinc enhances lipopolysaccharide-induced monkine secretion by alteration of fluidity state of lipopolysaccharide. J. Immunol. 157, 31393145.
31. Delamaire, M., Maugendre, D., Morcno, M., Le GolT, M., Allannic, H. and Genetet, B. (1997) Impaired leucocyte functions in diabetic patients. Diabetic Med. 14, 29-34.
32. Mowat, A.G. and Baum, J. (1971) Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. New Engl. J. Med. 284, 621-627.
33. Balasoiu, D., van Kessel, K.C., van Kats-Renaud, H.J., Collet, T.J. and Hoepelman, A.I. (1997) Granulocyte function in women with diabetes and asymptomatic bactcriuria. Diabetes Care 20, 392-395.
34. Bagdade, J.D., Stewart, M. and Walters, E. (1978) Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 27, 677681.
35. Bagdade, J.D. and Walters, E. (19SO) Impaired granulocyte adherence in mildly diabetic patients. Effects of tolazamide treatment. Diabetes 29, 309-311.
36. Marhofier, W., Stein, M., Maeser, E. and Federlin, K. (1992) Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 15, 256-260.
37. Gin, H., Brottier, E. and Aubertin, J. (1984) Influence of glycaemic normalisation by an artificial pancreas on phagocytic and bactericidal functions of granulocytes in insulin dependent diabetic patients. J. Clin. Pathol. 37, 1029-1031.
38. Saeed, F. and Castle, G.E. (1998) Neutrophil chemiluminescenee during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: Implications for diabetic susceptibility to infections. Clin. Diagn. Lab. Immunol. 5, 740-743.
39. Shah, S.V., Wallin, J.D. and Eilen, S.D. (1983) Chemiluminescence and Superoxide anion production by leukocytes from diabetic patients. J. Clin. Endocrinol. Metab. 57, 402-409.
40. Katz, S., Klein, B., Elian, I., Fishman, P. and Djaldetti, M. (1983) Phagocytotic activity of monocytes from diabetic patients. Diabetes Care 6, 479-482.
41. Schaeffer, A.J., Jones, J.M. and Dünn, J.K. (1981) Association of in vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary-tract infections. New Engl. J. Med. 304, 1062-1066.
42. Aly, F.Z., Blackwell, C.C., Mackenzie, D.A.C., Weir, D.M. and Clarke, B.F. (1992) Factors influencing oral carriage of yeasts among individuals with diabetes mellitus. Epidemiol. Infect. 109, 507-518.
43. Cameron, B.J. and Douglas, L.J. (1996) Blood group glycolipids as epithelial cell receptors for Candida albicans. Infect. Immun. 64, 891-896.
44. Weinmeister, K.D. and Dal Nogare, A.R. (1994) Buccal cell carbohydrates are altered during critical illness. Am. J. Respir. Crit. Care Med. 150, 131-134.
45. Darwazeh, A.M.G., Lamey, P.J., Samaranayake, L.P., MacFarlane, T.W., Fisher, B.M., MacRury, S.M. and Maccuish, A.C. (1990) The relationship between colonisation, secretor status and in vitro adhesion of Candida albicans to buccal epithelial cells from diabetics. J. Med. Microbiol. 33, 4349.